Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...21222324252627282930...
CompanyDrug NameStatusIndication Group
ConjuChem PC-DAC:Exendin-4 in Phase IIAlimentary tract & metabolism
GlaxoSmithKline Paxil CR in Phase IIINervous system
GlaxoSmithKline Paxil CR Approved in USAGenito urinary system & sex hormones
GlaxoSmithKline Paxil CR Approved in USAGenito urinary system & sex hormones
Angiotech Paxceed in Phase IIMusculoskeletal system
Angiotech Paxceed accomplished Phase IDermatologicals
Alcon Laboratories PATANOL Approved in N/ASensory organs
Bristol-Myers Squibb PARGLUVA discontinuedAlimentary tract & metabolism
UCB Pharma Parcopa Approved in USANervous system
EntreMed Panzem NCD and Avastin in Phase IIAntineoplastic & immunomodulating agents
EntreMed Panzem NCD accomplished Phase IIAntineoplastic & immunomodulating agents
EntreMed Panzem NCD in Phase IIAntineoplastic & immunomodulating agents
EntreMed Panzem and Taxotere accomplished Phase IAntineoplastic & immunomodulating agents
EntreMed Panzem accomplished Phase IIAntineoplastic & immunomodulating agents
Therion Biologics PANVAC -VF and Taxotere in Phase IIAntineoplastic & immunomodulating agents
Therion Biologics PANVAC -VF and Dozetaxel in Phase IIAntineoplastic & immunomodulating agents
Therion Biologics PANVAC -VF accomplished Phase IIIAntineoplastic & immunomodulating agents
Spectrum Ozarelix in Phase IIAntineoplastic & immunomodulating agents
AETERNA ZENTARIS ozarelix accomplished Phase IIAntineoplastic & immunomodulating agents
AETERNA ZENTARIS ozarelix accomplished Phase IIGenito urinary system & sex hormones
...21222324252627282930...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.